Journal of Inflammatory Bowel Diseases & Disorders

COVID-19 is a Severe Acute Respiratory Syndrome caused by the Coronavirus (SARS-CoV-2) that was described in China in late 2019 and led
to a global pandemic.
The devastating effect of this infection is due to its high contagion, although mild forms predominate, severe cases and mortality are very high
especially in patients with comorbidities and immunosuppression, raising the question of infection in patients with IBD who are often impaired
and on immunosuppressants or anti TNF. Due to the recent nature of the infection and the shortage of studies, we considered it interesting to
share our IBD experience through a series of eight IBD patients who presented with coronavirus infection.